ASPIRIN-EXACERBATED RESPIRATORY DISEASE

This adverse event was reported 615 times

These drugs are most commonly taken by patients reporting ASPIRIN-EXACERBATED RESPIRATORY DISEASE:

# Drug Count
0 ASPIRIN 198
1 IBUPROFEN 197
2 IBUPFROFEN 195
3 IBUPROFEN 200 MG 195
4 IBUPROFEN 200MG 195
5 IBUPROFEN CAPSULE 195
6 IBUPROFEN CAPSULES 200 MG 195
7 IBUPROFEN ORAL 195
8 IBUPROFEN TABLET, FILM COATED 195
9 IBUPROFEN TABLET, FILM-COATED 195
See all common drugs associated with ASPIRIN-EXACERBATED RESPIRATORY DISEASE

ASPIRIN-EXACERBATED RESPIRATORY DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZILEUTON 3 0.0046
1 FLURBIPROFEN 5 0.0033
2 ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE 1 0.0030
3 AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE 9 0.0022
4 RESLIZUMAB 1 0.0015
5 KETOPROFEN 17 0.0013
6 IBUPFROFEN 195 0.0010
7 IBUPROFEN TABLETS USP, 200MG 195 0.0010
8 IBUPROFEN ORAL 195 0.0010
9 IBUPROFEN CAPSULES 200 MG 195 0.0010
See all drugs enriched for association with ASPIRIN-EXACERBATED RESPIRATORY DISEASE

ASPIRIN-EXACERBATED RESPIRATORY DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 5-Lipoxygenase Inhibitor [EPC] 3 0.0046
1 Interleukin-5 Antagonist [EPC] 1 0.0015
2 Antiseptic [EPC] 2 0.0005
3 Platelet Aggregation Inhibitor [EPC] 202 0.0004
4 Nonsteroidal Anti-inflammatory Drug [EPC] 392 0.0003
5 Anti-coagulant [EPC] 1 0.0003
6 Leukotriene Receptor Antagonist [EPC] 6 0.0002
7 Histamine-1 Receptor Antagonist [EPC] 11 0.0001
8 Anti-IgE [EPC] 11 0.0001
9 Cephalosporin Antibacterial [EPC] 1 0.0001
See all drug classes enriched for association with ASPIRIN-EXACERBATED RESPIRATORY DISEASE